204 related articles for article (PubMed ID: 18606440)
1. Current techniques in screening for cervical cancer in Spain: updated recommendations.
Puig-Tintoré LM; Torné A; Alonso I
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
[TBL] [Abstract][Full Text] [Related]
2. Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain.
Puig-Tintoré LM; Castellsagué X; Torné A; de Sanjosé S; Cortés J; Roura E; Méndez C; Bosch FX
J Low Genit Tract Dis; 2008 Apr; 12(2):82-9. PubMed ID: 18369300
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
4. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy.
Massad LS; Verhulst SJ; Hagemeyer M; Brady P
J Low Genit Tract Dis; 2006 Oct; 10(4):252-5. PubMed ID: 17012992
[TBL] [Abstract][Full Text] [Related]
6. Results of a cervical cancer screening programme from an area of Barcelona (Spain) with a large immigrant population.
Casamitjana M; Sala M; Ochoa D; Fusté P; Castells X; Alameda F;
Eur J Public Health; 2009 Oct; 19(5):499-503. PubMed ID: 19435798
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
8. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
9. Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence.
Martín-López R; Hernández-Barrera V; de Andres AL; Carrasco-Garrido P; de Miguel AG; Jimenez-Garcia R
Eur J Cancer Prev; 2012 Jan; 21(1):82-8. PubMed ID: 22129658
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
12. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
[TBL] [Abstract][Full Text] [Related]
13. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
15. [Proposal of cervical cancer early detection programme in Croatia].
Znaor A; Babić D; Corusić A; Grce M; Mahovlić V; Pajtler M; Serman A
Lijec Vjesn; 2007 May; 129(5):158-63. PubMed ID: 17695198
[TBL] [Abstract][Full Text] [Related]
16. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
19. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
20. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
Hølund B; Grinsted P
Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
